99 related articles for article (PubMed ID: 38662551)
21. The Alternative RelB NF-kB Subunit Exerts a Critical Survival Function upon Metabolic Stress in Diffuse Large B-Cell Lymphoma-Derived Cells.
Nuan-Aliman S; Bordereaux D; Thieblemont C; Baud V
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203557
[TBL] [Abstract][Full Text] [Related]
22. Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma.
Stirm K; Leary P; Bertram K; Núñez NG; Wüst D; Boudesco C; Verhoeyen E; Zenz T; Becher B; Menter T; Tzankov A; Müller A
Oncoimmunology; 2021; 10(1):2003533. PubMed ID: 34858727
[TBL] [Abstract][Full Text] [Related]
23. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma.
Eluard B; Nuan-Aliman S; Faumont N; Collares D; Bordereaux D; Montagne A; Martins I; Cagnard N; Caly M; Taoui O; Lordello L; Lehmann-Che J; Tesson B; Martinez-Climent JA; Copie-Bergman C; Haioun C; Tilly H; Bonsang B; Vincent-Salomon A; Jais JP; Jardin F; Leroy K; Maiuri MC; Kroemer G; Molina TJ; Feuillard J; Baud V
Blood; 2022 Jan; 139(3):384-398. PubMed ID: 34232979
[TBL] [Abstract][Full Text] [Related]
24. Characterization of DLBCL with a PMBL gene expression signature.
Duns G; Viganò E; Ennishi D; Sarkozy C; Hung SS; Chavez E; Takata K; Rushton C; Jiang A; Ben-Neriah S; Woolcock BW; Slack GW; Hsi ED; Craig JW; Hilton LK; Shah SP; Farinha P; Mottok A; Gascoyne RD; Morin RD; Savage KJ; Scott DW; Steidl C
Blood; 2021 Jul; 138(2):136-148. PubMed ID: 33684939
[TBL] [Abstract][Full Text] [Related]
25. Diffuse Large B-Cell Lymphoma.
Sehn LH; Salles G
N Engl J Med; 2021 Mar; 384(9):842-858. PubMed ID: 33657296
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures.
Kotlov N; Bagaev A; Revuelta MV; Phillip JM; Cacciapuoti MT; Antysheva Z; Svekolkin V; Tikhonova E; Miheecheva N; Kuzkina N; Nos G; Tabbo F; Frenkel F; Ghione P; Tsiper M; Almog N; Fowler N; Melnick AM; Leonard JP; Inghirami G; Cerchietti L
Cancer Discov; 2021 Jun; 11(6):1468-1489. PubMed ID: 33541860
[TBL] [Abstract][Full Text] [Related]
27. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.
Yu H; Lin L; Zhang Z; Zhang H; Hu H
Signal Transduct Target Ther; 2020 Sep; 5(1):209. PubMed ID: 32958760
[TBL] [Abstract][Full Text] [Related]
28. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
Wright GW; Huang DW; Phelan JD; Coulibaly ZA; Roulland S; Young RM; Wang JQ; Schmitz R; Morin RD; Tang J; Jiang A; Bagaev A; Plotnikova O; Kotlov N; Johnson CA; Wilson WH; Scott DW; Staudt LM
Cancer Cell; 2020 Apr; 37(4):551-568.e14. PubMed ID: 32289277
[TBL] [Abstract][Full Text] [Related]
29. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
Lacy SE; Barrans SL; Beer PA; Painter D; Smith AG; Roman E; Cooke SL; Ruiz C; Glover P; Van Hoppe SJL; Webster N; Campbell PJ; Tooze RM; Patmore R; Burton C; Crouch S; Hodson DJ
Blood; 2020 May; 135(20):1759-1771. PubMed ID: 32187361
[TBL] [Abstract][Full Text] [Related]
30. Role of Regulatory B Cells in the Progression of Cervical Cancer.
Chen Z; Zhu Y; Du R; Pang N; Zhang F; Dong D; Ding J; Ding Y
Mediators Inflamm; 2019; 2019():6519427. PubMed ID: 31316301
[TBL] [Abstract][Full Text] [Related]
31. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
Mottok A; Hung SS; Chavez EA; Woolcock B; Telenius A; Chong LC; Meissner B; Nakamura H; Rushton C; Viganò E; Sarkozy C; Gascoyne RD; Connors JM; Ben-Neriah S; Mungall A; Marra MA; Siebert R; Scott DW; Savage KJ; Steidl C
Blood; 2019 Sep; 134(10):802-813. PubMed ID: 31292115
[TBL] [Abstract][Full Text] [Related]
32. Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
Davies A; Cummin TE; Barrans S; Maishman T; Mamot C; Novak U; Caddy J; Stanton L; Kazmi-Stokes S; McMillan A; Fields P; Pocock C; Collins GP; Stephens R; Cucco F; Clipson A; Sha C; Tooze R; Care MA; Griffiths G; Du MQ; Westhead DR; Burton C; Johnson PWM
Lancet Oncol; 2019 May; 20(5):649-662. PubMed ID: 30948276
[TBL] [Abstract][Full Text] [Related]
33. Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Younes A; Sehn LH; Johnson P; Zinzani PL; Hong X; Zhu J; Patti C; Belada D; Samoilova O; Suh C; Leppä S; Rai S; Turgut M; Jurczak W; Cheung MC; Gurion R; Yeh SP; Lopez-Hernandez A; Dührsen U; Thieblemont C; Chiattone CS; Balasubramanian S; Carey J; Liu G; Shreeve SM; Sun S; Zhuang SH; Vermeulen J; Staudt LM; Wilson W;
J Clin Oncol; 2019 May; 37(15):1285-1295. PubMed ID: 30901302
[TBL] [Abstract][Full Text] [Related]
34. IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation.
Wang X; Li J; Lu C; Wang G; Wang Z; Liu X; Liu B; Wang G; Zhang Q; Yang Q
Exp Cell Res; 2019 Mar; 376(2):192-197. PubMed ID: 30711567
[TBL] [Abstract][Full Text] [Related]
35. Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.
Ansell SM; Minnema MC; Johnson P; Timmerman JM; Armand P; Shipp MA; Rodig SJ; Ligon AH; Roemer MGM; Reddy N; Cohen JB; Assouline S; Poon M; Sharma M; Kato K; Samakoglu S; Sumbul A; Grigg A
J Clin Oncol; 2019 Feb; 37(6):481-489. PubMed ID: 30620669
[TBL] [Abstract][Full Text] [Related]
36. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
[TBL] [Abstract][Full Text] [Related]
37. Induction and transcriptional regulation of the co-inhibitory gene module in T cells.
Chihara N; Madi A; Kondo T; Zhang H; Acharya N; Singer M; Nyman J; Marjanovic ND; Kowalczyk MS; Wang C; Kurtulus S; Law T; Etminan Y; Nevin J; Buckley CD; Burkett PR; Buenrostro JD; Rozenblatt-Rosen O; Anderson AC; Regev A; Kuchroo VK
Nature; 2018 Jun; 558(7710):454-459. PubMed ID: 29899446
[TBL] [Abstract][Full Text] [Related]
38. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Chapuy B; Stewart C; Dunford AJ; Kim J; Kamburov A; Redd RA; Lawrence MS; Roemer MGM; Li AJ; Ziepert M; Staiger AM; Wala JA; Ducar MD; Leshchiner I; Rheinbay E; Taylor-Weiner A; Coughlin CA; Hess JM; Pedamallu CS; Livitz D; Rosebrock D; Rosenberg M; Tracy AA; Horn H; van Hummelen P; Feldman AL; Link BK; Novak AJ; Cerhan JR; Habermann TM; Siebert R; Rosenwald A; Thorner AR; Meyerson ML; Golub TR; Beroukhim R; Wulf GG; Ott G; Rodig SJ; Monti S; Neuberg DS; Loeffler M; Pfreundschuh M; Trümper L; Getz G; Shipp MA
Nat Med; 2018 May; 24(5):679-690. PubMed ID: 29713087
[TBL] [Abstract][Full Text] [Related]
39. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Schmitz R; Wright GW; Huang DW; Johnson CA; Phelan JD; Wang JQ; Roulland S; Kasbekar M; Young RM; Shaffer AL; Hodson DJ; Xiao W; Yu X; Yang Y; Zhao H; Xu W; Liu X; Zhou B; Du W; Chan WC; Jaffe ES; Gascoyne RD; Connors JM; Campo E; Lopez-Guillermo A; Rosenwald A; Ott G; Delabie J; Rimsza LM; Tay Kuang Wei K; Zelenetz AD; Leonard JP; Bartlett NL; Tran B; Shetty J; Zhao Y; Soppet DR; Pittaluga S; Wilson WH; Staudt LM
N Engl J Med; 2018 Apr; 378(15):1396-1407. PubMed ID: 29641966
[TBL] [Abstract][Full Text] [Related]
40. Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone.
Horvat M; Zadnik V; Južnič Šetina T; Boltežar L; Pahole Goličnik J; Novaković S; Jezeršek Novaković B
Oncol Lett; 2018 Mar; 15(3):3602-3609. PubMed ID: 29467881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
